Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.21.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock issuable upon conversion, shares 2,092,186 113,260
Common stock issuable upon conversion $ 458,091 $ 11,315
Convertible Notes Payable One [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock issuable upon conversion, shares 4,368,486 7,936,740
Common stock issuable upon conversion $ 1,186,176 $ 793,674
Beneficial ownership limitations percentage 4.99% 4.99%